ghasemi, ghasem, motahary, babak, Sayadikordabadi, robabe, Alizadehdakhel, Asghar. (1400). The Molecular Docking and Molecular Dynamics Simulation of Some HIV-1 protease Inhibitors For the treatment of Coronavirus Disease-19. , 19(1), 1-7. doi: 10.30495/jptc.2023.65656.1233
ghasem ghasemi; babak motahary; robabe Sayadikordabadi; Asghar Alizadehdakhel. "The Molecular Docking and Molecular Dynamics Simulation of Some HIV-1 protease Inhibitors For the treatment of Coronavirus Disease-19". , 19, 1, 1400, 1-7. doi: 10.30495/jptc.2023.65656.1233
ghasemi, ghasem, motahary, babak, Sayadikordabadi, robabe, Alizadehdakhel, Asghar. (1400). 'The Molecular Docking and Molecular Dynamics Simulation of Some HIV-1 protease Inhibitors For the treatment of Coronavirus Disease-19', , 19(1), pp. 1-7. doi: 10.30495/jptc.2023.65656.1233
ghasemi, ghasem, motahary, babak, Sayadikordabadi, robabe, Alizadehdakhel, Asghar. The Molecular Docking and Molecular Dynamics Simulation of Some HIV-1 protease Inhibitors For the treatment of Coronavirus Disease-19. , 1400; 19(1): 1-7. doi: 10.30495/jptc.2023.65656.1233
The Molecular Docking and Molecular Dynamics Simulation of Some HIV-1 protease Inhibitors For the treatment of Coronavirus Disease-19
1Department of Chemistry and Chemical Engineering, Rasht Branch, Islamic Azad University, Rasht, Iran
2Depatment of Computer Engineering, Rasht Branch, Islamic Azad University, Rasht, Iran
چکیده
In this manuscript; Molecular dynamics simulation was tested on COVID -19 main protease (PDB: 6LU7) with the docking studies have been employed using autodock-vina-1.1.2-4 and autodock- mgltools-1.5.6 (flex) programs to evaluate the interactions. HIV-1 Protease is a prerequisite for viral replication. In this manuscript; Molecular dynamics simulation was tested on COVID -19 main protease (PDB: 6LU7) with the docking studies have been employed using autodock-vina-1.1.2-4 and autodock- mgltools-1.5.6 (flex) programs to evaluate the interactions. Regular and Flexible docking approaches were run. Molecular dynamics simulation was tested on COVID -19 main protease (PDB: 6LU7) with molecule 7. Drug-likeness descriptors of compounds such as logP (partition coefficient), H-Bond Acceptor (HBA), H-Bond Donor (HBD), number of Rotable Bond (nRB), and nHB calculated by DruLiTo. In the molecular docking study, the maximum binding affinity of -5.9 kcal/mol was obtained between each of COVID -19 main protease (PDB: 6LU7) enzyme systems and the geometric-optimized molecules, representing a strong interaction. The reference molecule PRD_002214 of Mpro forms four hydrogen bonds with Glu 166, Phe 140, Gln 189, His 163, and some hydrophobic bonds. In this study, molecules 7 (Amprenavir) and 15 were presented as the most stable ones that may be introduced for further investigations, including clinical experiments.
تازه های تحقیق
REFERENCES
Barré-Sinoussi, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret and j. Gruest, Science, 220(4599) (1983) 868 -871.
C. Gallo, S. Z. Salahuddin, M. Popovic, G. M. Shearer, M. Kaplan and B. F. Haynes, Science,224(4648) (1984) 500 -503.
Brouwers, J. Tack, F. Lammert and P. Augustijns , J. pharm. sci. 95(2) (2006) 372- 383.
Ford, S. H. Khoo and D. J. Back, J. Antimicrob. Chemother.54(6) (2004) 982–990.
M. Corman, O. Landt and M. Kaiser, Euro. Surveill. 25(3) (2020) 2000045.
Liu, B. Zhang, Z. Jin, H. Yang and Z. Rao. PDB code 6LU7.
Roy, A. Kucukural and Y. Zhang. Nat. Protoc. 5(4) (2010) 725-738.
M. Elokely and R. J. Doerksen, J. Chem. Inf. Model. 53(8) (2013) 1934-1945.
Zhang, H. W. Zhao, Y. Y. H. Dai, X. C. Du and P. Y. Tang ,RSC Adv, 5(2015) 12678-12685.
Y. Shih, M. V. Shugaev, C. Wu and LV. Zhigilei. J Phys. Chem C. 121(30) (2017) 16549-16567.
M. Mills, M. Nelson, D. Jayaweera, K. Ruxrungtham, I. Cassetti, P. M. Girard, C. Workman, I. Dierynck, V. Sekar and C. V. Abeele, AIDS, 23 (2009) 1679–1688.
Yamamoto, R. Yang, Y. Yoshinaka, S. Amari, T. Nakano, J. Cinatl, H. Rabenau, H. W. Doer and G. Hunsmann and A. Otaka, Biochem. Biophys. Res. Commun. 318 (2004) 719– 725.
Boffito, I. Arnaudo, R. Raiteri, S. Bonora, A. Sinicco, A. D. Garbo, H. E. Reynolds, P. G. Hoggard, D. J. Back and G. D. Perri, AIDS, 16 (2002) 2081–2083.
Bolcato, M. Bissaro, M. Pavan, M. Sturlese and S. Moro, Sci. Rep. 10 (2020) 20927.
B. Cardoso and S. A. Mendanha, J. Mol. Struct. 1225 (2021) 129143.
M. Corman, O. Landt and M. Kaiser, Euro. Surveill. 25(3) (2020) 2000045.
Liu, B. Zhang, Z. Jin, H. Yang and Z. Rao. PDB code 6LU7.
Roy, A. Kucukural and Y. Zhang. Nat. Protoc. 5(4) (2010) 725-738.
M. Elokely and R. J. Doerksen, J. Chem. Inf. Model. 53(8) (2013) 1934-1945.
Zhang, H. W. Zhao, Y. Y. H. Dai, X. C. Du and P. Y. Tang ,RSC Adv, 5(2015) 12678-12685.
Y. Shih, M. V. Shugaev, C. Wu and LV. Zhigilei. J Phys. Chem C. 121(30) (2017) 16549-16567.
M. Mills, M. Nelson, D. Jayaweera, K. Ruxrungtham, I. Cassetti, P. M. Girard, C. Workman, I. Dierynck, V. Sekar and C. V. Abeele, AIDS, 23 (2009) 1679–1688.
Yamamoto, R. Yang, Y. Yoshinaka, S. Amari, T. Nakano, J. Cinatl, H. Rabenau, H. W. Doer and G. Hunsmann and A. Otaka, Biochem. Biophys. Res. Commun. 318 (2004) 719– 725.
Boffito, I. Arnaudo, R. Raiteri, S. Bonora, A. Sinicco, A. D. Garbo, H. E. Reynolds, P. G. Hoggard, D. J. Back and G. D. Perri, AIDS, 16 (2002) 2081–2083.
Bolcato, M. Bissaro, M. Pavan, M. Sturlese and S. Moro, Sci. Rep. 10 (2020) 20927.
B. Cardoso and S. A. Mendanha, J. Mol. Struct. 1225 (2021) 129143.
1؛ babak motahary2؛ robabe Sayadikordabadi1؛ Asghar Alizadehdakhel1
